Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-25-062428
Filing Date
2025-06-25
Accepted
2025-06-25 09:24:42
Documents
1
Effectiveness Date
2025-06-25

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2518614d10_s8pos.htm S-8 POS 49973
  Complete submission text file 0001104659-25-062428.txt   51046
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-215793 | Film No.: 251071295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)